BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

SSORGANICS01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

SSORGANICS01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
08-Apr-2024	BC	Mark Corporate Advisors Pvt Ltd. ('Manager to the Offer') has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations 13(2)(g) and 15(1) of Securities and Ex	05-Jun-2024
08-Apr-2024	BC	Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we hereby inform you that the Board of Directors of the Company at its Board Meeting held today, April 08, 2024,	09-May-2024
03-Apr-2024	BC	Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/04/2024 inter alia to consider and approve This is to inform you that pursuant	08-Apr-2024
04-Mar-2024	BC	To Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-Executive Independent Director of the Company. The Board of Directors based on the recommendation of the Nomination and Remunerati	04-Mar-2024
04-Mar-2024	BC	To Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-Executive Independent Director of the Company. The Board of Directors based on the recommendation of the Nomination and Remunerati	04-Mar-2024

No Rights has been declared by SSORGANICS

Book Closure

Record Date	Split Date	Purpose
05-Jun-2024	01 Jan'1900	Mark Corporate Advisors Pvt Ltd. ('Manager to the Offer') has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations 13(2)(g) and 15(1) of Securities and Ex
09-May-2024	-	Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we hereby inform you that the Board of Directors of the Company at its Board Meeting held today, April 08, 2024,
08-Apr-2024	-	Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/04/2024 inter alia to consider and approve This is to inform you that pursuant
04-Mar-2024	-	To Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-Executive Independent Director of the Company. The Board of Directors based on the recommendation of the Nomination and Remunerati
04-Mar-2024	-	To Re-appointment of Mrs. Padmaja Surapureddy (DIN: 05358127) as Non-Executive Independent Director of the Company. The Board of Directors based on the recommendation of the Nomination and Remunerati

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
No items to show...

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	9.15	13.08	6.86	8.19	7.85	6.06
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	9.15	13.08	6.86	8.19	7.85	6.06
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.03	0.00	0.00	0.00	0.02	0.00
Total Income	9.18	13.08	6.86	8.19	7.87	6.06
Total Expenditure	11.67	15.08	10.63	10.49	10.52	7.89
PBIDT	-2.49	-2.00	-3.76	-2.30	-2.65	-1.84
Interest	0.36	0.34	0.29	0.94	0.20	0.10
PBDT	-2.86	-2.35	-4.06	-3.24	-2.85	-1.94
Depreciation	0.69	0.83	0.50	0.85	0.40	0.40
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.23	-0.02	0.00	0.20	0.00	0.00
Reported Profit After Tax	-3.78	-3.16	-4.56	-4.29	-3.25	-2.34
Extra-ordinary Items	-0.05	-0.03	-0.13	-0.05	-0.34	-0.34
Adjusted Profit After Extra-ordinary item	-3.73	-3.13	-4.43	-4.24	-2.91	-2.00

EPS (Unit Curr.)	-0.99	-0.87	-1.65	-3.02	-2.29	-1.64
EPS (Adj) (Unit Curr.)	-0.99	-0.87	-1.65	-3.02	-2.29	-1.64
Calculated EPS (Unit Curr.)	-1.13	-0.94	-1.36	-3.02	-2.29	-1.64
Calculated EPS (Adj) (Unit Curr.)	-1.13	-0.94	-1.36	-3.02	-2.29	-1.64
Calculated EPS (Ann.) (Unit Curr.)	-4.51	-3.77	-5.45	-12.09	-9.16	-6.58
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-4.51	-3.77	-5.45	-12.09	-9.16	-6.58
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	33.48	33.48	33.48	14.20	14.20	14.20
Reserve & Surplus	0.00	0.00	0.00	-60.40	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-27.21	-15.29	-54.81	-28.08	-33.76	-30.36
PBDTM(%)	-31.26	-17.97	-59.18	-39.56	-36.31	-32.01
PATM(%)	-41.31	-24.16	-66.47	-52.38	-41.40	-38.61

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	14.20	14.20	10.20	10.20	10.20	10.20
Reserves Total	-60.40	-48.83	-48.22	-51.15	-45.36	-42.11
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-46.20	-34.63	-38.02	-40.95	-35.16	-31.91
Secured Loans	42.75	33.86	2.85	0.50	0.50	1.76
Unsecured Loans	25.24	18.27	45.04	26.42	21.84	17.39
Total Debt	67.99	52.13	47.89	26.92	22.34	19.15
Total Liabilities	21.79	17.50	9.87	-14.03	-12.82	-12.76
APPLICATION OF FUNDS :
Gross Block	46.43	36.44	31.18	25.10	24.58	23.99
Less : Accumulated Depreciation	18.52	16.46	14.87	13.68	12.68	11.70
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	27.91	19.98	16.31	11.42	11.90	12.29
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.34	0.65	0.00	0.00	0.06
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.05	0.05	0.05	0.05	0.05	0.05
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	11.71	7.28	12.11	4.25	5.33	1.56
Sundry Debtors	10.16	1.58	1.61	0.42	0.51	0.48
Cash and Bank	0.11	0.16	0.45	0.12	0.02	0.01
Loans and Advances	3.04	0.55	1.77	1.98	2.94	2.20
Total Current Assets	25.01	9.56	15.94	6.77	8.80	4.24
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	24.32	6.87	14.56	14.52	15.56	16.01
Provisions	0.52	0.12	0.09	0.97	0.98	1.00
Total Current Liabilities	24.84	6.98	14.65	15.50	16.54	17.01
Net Current Assets	0.16	2.58	1.30	-8.73	-7.73	-12.77
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	1.66	1.46	1.34	0.00	0.00	1.52
Net Deferred Tax	-1.66	-1.46	-1.34	0.00	0.00	-1.52
Total Assets	26.46	21.49	16.98	2.74	4.22	-1.89
Contingent Liabilities	0.00	0.00	1.20	1.20	1.20	1.20

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.16	0.45	0.12	0.02	0.01
Net Cash from Operating Activities	-1.63	-1.68	-1.62	-2.59	-7.79
Net Cash Used In Investing Activities	-9.64	-4.94	-6.72	-0.50	-0.56
Net Cash Used In Financing Activities	11.22	6.33	8.67	3.19	8.36
Net Inc./Dec In Cash And Cash Equivalents	-0.05	-0.29	0.33	0.10	0.01
Cash And Cash Equivalents At End Of The Year	0.11	0.16	0.45	0.12	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

29.73%

FII Shareholding

0.00%

DII Shareholding

0.03%

Public Shareholding

70.25%

**Promoter pledged shareholding 29.73%

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 113.84 crores. It has reported a sales of Rs. 9.15 crores and a net profit of Rs. -3.78 crores for the quarter ended December 2018. The company management includes Sai Sudhakar Vankineni, Sai Sudhakar Vankineni,D Vidya Sagar,Muralidhar R,Sangari Kondal Reddy,Padmaja Surapureddy,Kanuganti Raghavender Rao,Sravani Reddy Gantla,Bharath Reddy Guntuku,Dolly Mandhan (Oxygenta Pharmaceutical Ltd) among others.

Chairman

Sai Sudhakar Vankineni

Registered office

Survey No 252/1 Aroor Village,Sadasivapet Mandal,Medak,Telangana,502291

FAX :91-08455-250090

Background

Incorporation Year1990

Face Value₹10

Market Lot100

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0